References
- Clawson B M, Bell E T. Incidence of fatal coronary disease in nondiabetic and diabetic persons. Arch Pathol 1949; 48: 105–8
- Karlefors T. Circulatory studies in male diabetics. Thesis Acta Med Scand, 1966, Suppl. 499
- Thomsen Aa C. The kidney in diabetes mellitus. Thesis, Munksgaard, Copenhagen 1965
- Neubauer B. A quantitative study of peripheral arterial calcification and glucose tolerance in elderly diabetics and non‐diabetics. Diabetologia 1971; 7: 409–13
- Ledet T. Histological and histochemical changes in the coronary arteries of old diabetic patients. Diabetologia 1968; 4: 268–72
- Billimoria J D, Isaacs A J, Melkik K. A lipid and lipoprotein profile of treated and untreated diabetics. Ann Clin Biochem 1976; 13: 315–21
- Nikkila E A, Hormila P. Serum lipids and lipoproteins in insulin treated diabetics. Demonstration of increased high‐density lipoprotein concentrations. Diabetes 1978; 27: 1078–86
- Nestel P, Billington T, Tada N, Nugent P, Fidge N. Heterogenity of very‐low‐density lipoprotein metabolism in hyperlipemic subjects. Metabolism 1983; 32: 810–7
- Pietri A, Dunn F L, Raskin P. The effect of improved diabetic control on plasma lipid and lipoprotein levels. Diabetes 1980; 29: 1001–5
- Tamborlane V W, Sherwin R S, Genel M, Felig P. Restoration of normal lipid and amino acid metabolism in diabetic patients treated with a portable insulin‐infusion pump. Lancet 1979; 6: 1258–61
- Vlachokosta V K, Cader Asmal A, Ganda P, Aoki T. The effect of strict control with the artificial beta‐cell on plasma lipid levels in insulin dependent diabetes. Diabetes Care 1983; 6: 351–5
- Pietri O A, Grundy S M, Raskin P. The effect of continuous subcutaneous insulin infusion on very‐low‐density lipoprotein triglyceride metabolism in type I diabetes mellitus. Diabetes 1983; 32: 75–81
- Dunn F L, Pietri O A, Raskin P. Plasma lipid and lipoprotein levels with continuous subcutaneous insulin infusion in type I diabetes mellitus. Ann Intern Med 1981; 95: 426–31
- Tatami R, et al. Intermediate‐density lipoprotein and cholesterol‐rich very‐low‐density lipoprotein in angiographically determined coronary artery disease. Circulation 1981; 64: 1174–84
- Schelburne F A, Quarfordt S H. The interaction of heparin with an apoprotein of human very‐low‐density lipoprotein. J Clin Invest 1977; 60: 944–50
- Gianturco S H, Gotto A M, Jacson R, Patsch J R, Sybers H D, Taunton O D, Yeshuron D, Smith L C. Control of 3‐hydroxy‐3‐methylglutaryl‐Co A reductase activity in cultured human fibroblasts by very‐low‐density lipoproteins of subjects with hypertriglyceridemia. J Clin Invest 1978; 61: 320–8
- Poyser A, Nestel P J. Metabolism of very‐low‐density lipoproteins by human mononuclear cells. Artery 1979; 6: 122–43